A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extensionfor PAHDrug: Ralinepag48 locations incl. PhoenixSponsor: United TherapeuticsSex: All·Age: 18+Code: NCT03683186·Phase 3·Enrolling By Invitation
Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)for Brain Tumor Adult1 location in DallasSponsor: University of Texas Southwestern Medical CenterSex: All·Age: 18 - 70Code: NCT03067467·RecruitingApply to this trial
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Studyfor Lower Respiratory Tract Infection49 locations incl. DuarteSponsor: Ansun Biopharma, Inc.Sex: All·Age: All agesCode: NCT03808922·Phase 3·RecruitingApply to this trial
Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimagingfor Parkinson Disease1 location in DallasSponsor: University of Texas Southwestern Medical CenterSex: All·Age: All ages·Accepts healthy volunteersCode: NCT03872102·RecruitingApply to this trial
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillancefor Prostate Cancer1 location in DallasSponsor: University of Texas Southwestern Medical CenterSex: Male·Age: 40 - 89Code: NCT03769766·Phase 3·RecruitingApply to this trial
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cellsfor Neoplasms100 locations incl. BirminghamSponsor: CelgeneSex: All·Age: All agesCode: NCT03435796·Phase 2, Phase 3·RecruitingApply to this trial
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphomafor Metastatic Castration Resistant Prostate Cancer (mCRPC)Drug: Mevrometostat45 locations incl. TucsonSponsor: PfizerSex: All·Age: 18+Code: NCT03460977·Phase 1·RecruitingApply to this trial
The PREDICT Registry:for DCIS30 locations incl. ScottsdaleSponsor: PreludeDxSex: Female·Age: 30 - 85Code: NCT03448926·RecruitingApply to this trial
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)for Relapsed Hematologic MalignancyDrug: Emavusertib27 locations incl. PhoenixSponsor: Curis, Inc.Sex: All·Age: 18+Code: NCT03328078·Phase 1, Phase 2·RecruitingApply to this trial
No Surgery Trial / Two Dose-escalation Strategiesfor Stage II Rectal Cancer1 location in DallasSponsor: Sir Mortimer B. Davis - Jewish General HospitalSex: All·Age: 18 - 80Code: NCT03051464·Phase 2, Phase 3·RecruitingApply to this trial
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangementsfor Locally Advanced Solid TumorsDrug: Repotrectinib49 locations incl. DuarteSponsor: Turning Point Therapeutics, Inc.Sex: All·Age: 12+Code: NCT03093116·Phase 1, Phase 2·RecruitingApply to this trial
A Randomized Multicenter Study for Isolated Skin Vasculitisfor Primary Cutaneous Vasculitis12 locations incl. Kansas CitySponsor: University of PennsylvaniaSex: All·Age: 18+Code: NCT02939573·Phase 2·RecruitingApply to this trial
MEASuRE: Metreleptin Effectiveness And Safety Registryfor Generalised Lipodystrophy16 locations incl. BirminghamSponsor: Amryt PharmaSex: All·Age: All agesCode: NCT02325674·RecruitingApply to this trial
Multiple System Atrophy Multidisciplinary Clinicfor Multiple System Atrophy (MSA)1 location in DallasSponsor: University of Texas Southwestern Medical CenterSex: All·Age: 18+Code: NCT03811808·RecruitingApply to this trial
Pulmonary Hypertension Association Registryfor Pulmonary Arterial Hypertension52 locations incl. PhoenixSponsor: Pulmonary Hypertension Association, Inc.Sex: All·Age: 0+Code: NCT04071327·RecruitingApply to this trial
DExterous Hand Control Through Fascicular Targeting (DEFT) - (Human Subjects)for Amputation1 location in DallasSponsor: University of Texas Southwestern Medical CenterSex: All·Age: 18 - 95Code: NCT02994160·RecruitingApply to this trial
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)for Glioma3 locations incl. ManhassetSponsor: Plus TherapeuticsSex: All·Age: 18+Code: NCT01906385·Phase 1, Phase 2·RecruitingApply to this trial
Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancerfor Lung Cancer1 location in DallasSponsor: University of Texas Southwestern Medical CenterSex: All·Age: 18 - 99Code: NCT03563976·RecruitingApply to this trial
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomyfor Prostate Cancer1 location in DallasSponsor: yair lotanSex: Male·Age: 30 - 80Code: NCT02064673·Phase 3·RecruitingApply to this trial
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutationfor Relapsed or Refractory Acute Myeloid Leukemia (AML)26 locations incl. BirminghamSponsor: Institut de Recherches Internationales ServierSex: All·Age: 18+Code: NCT02074839·Phase 1·RecruitingApply to this trial
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participantsfor Unspecified Adult Solid Tumor, Protocol Specific1 location in DallasSponsor: University of Texas Southwestern Medical CenterSex: All·Age: 18+·Accepts healthy volunteersCode: NCT00992303·RecruitingApply to this trial
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).for IGF1 Deficiency7 locations incl. OrangeSponsor: Esteve Pharmaceuticals, S.A.Sex: All·Age: 2 - 18Code: NCT00903110·RecruitingApply to this trial
Identification of Genomic Predictors of Adverse Events After Cardiac Surgeryfor Heart3 locations incl. BostonSponsor: Brigham and Women's HospitalSex: All·Age: 20 - 90Code: NCT01258231·RecruitingApply to this trial
NARCOMS Registry: A Multiple Sclerosis Registryfor Multiple Sclerosis1 location in DallasSponsor: University of Texas Southwestern Medical CenterSex: All·Age: 18+Code: NCT01018537·RecruitingApply to this trial